Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: A population-based study

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Haghshenas, Mohammadreza ^a   Golini Moghaddam, Tahereh ^a   Rafiei, Alireza ^a   Emadeian, Omid ^a   Shykhpour, Ahmad ^a   Ashrafi, G Hossein ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Cervical cancer; Genotype of HPV; Human papillomavirus; PCR

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPING TECHNIQUE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 84878430256     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-20     Document Type: Article

References (29)

1. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Lancet 2011 378 1461 84 10.1016/S0140-6736(11)61351-2 21924486
2. The natural history of cervical HPV infection: unresolved issues. Woodman CB, Collins SI, Young LS, Nat Rev Cancer 2007 7 11 22 10.1038/nrc2050 17186016
3. Cancer in developing countries. Boffetta P, Parkin DM, CA Cancer J Clin 1994 44 81 90 10.3322/canjclin.44.2.81 8124607
4. Human papillomavirus: the most significant risk determinant of cervical intraepithelial neoplasia. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ, Int J Cancer 1996 65 601 606 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6 8598310
5. Detection of Cervical Infections in Colposcopy Clinic Patients. Lanham S, Herbert A, Basarab A, Watt P, J Clin Microbiol 2001 39 2946 2950 10.1128/JCM.39.8.2946-2950.2001 11474018
6. Real-Time PCR Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer. Moberg M, Gustavsson I, Gyllensten U, J Clin Microbiol 2003 41 3221 3228 10.1128/JCM.41.7.3221-3228.2003 12843067
7. Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas. Kraus I, Molden T, Holm R, Lie AK, Karlsen F, Kristensen GB, Skomedal H, J Clin Microbiol 2006 2006 44 1310 1317
8. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, J Pathol 1999 189 12 19 10.1002/(SICI)1096-9896(199909)189:1<12::AID- PATH431>3.0.CO;2-F 10451482
9. The causal relation between human papillomavirus and cervical cancer. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV, J Clin Pathol 2002 55 244 265 10.1136/jcp.55.4.244 11919208
10. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG, Am J Pathol 2003 162 747 53 10.1016/S0002-9440(10)63871-0 12598309
11. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ, Fuchs PG, Cancer 2001 92 2875 84 10.1002/1097-0142(20011201)92:11<2875::AID-CNCR10130>3.0. CO;2-7 11753961
12. Epidemiologic classification of human papillomavirus types associated with cervical cancer. Munoz N, Bosch FX, De Sanjose S, Herrero R, Castellsague X, Shah KV, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259
13. Human papillomavirus and cancer: the epidemiological evidence. Munoz N, J Clin Virol 2000 19 1 5 10.1016/S1386-6532(00)00125-6 11091143
14. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, Br J Cancer 2003 88 63 73 10.1038/sj.bjc.6600688 12556961
15. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Munoz N, Bosch FX, De Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, Int J Cancer 1992 52 743 9 10.1002/ijc.2910520513 1330933
16. Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy. Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Cancer Epidemiol Biomarkers Prev 2010 19 2389 2400 10.1158/1055-9965.EPI-10-0131 20826836
17. Human papillomavirus types in women with cervical cancer in Haifa District. Siegler E, Lahat N, Shiner M, Mackuli L, Aroudi Y, Shapiro S, Auslander R, Lavie O, Harefuah 2011 150 837 41, 876 22428203
18. Investigation of human papillomavirus, its types and variants. Gudleviciene Z, Didziapetriene J, Suziedelis K, Lapkauskaite L, Medicina (Kaunas) 2005 41 910 5
19. Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Liu J, Rose B, Huang X, Liao G, Carter J, Wu X, Thompson C, Gynecol Oncol 2004 94 803 10 10.1016/j.ygyno.2004.06.005 15350376
20. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, BMC Infect Dis 2005 5 116 10.1186/1471-2334-5-116 16371167
21. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Qiu AD, Wu EQ, Yu XH, Jiang CL, Jin YH, Wu YG, Chen Y, Chen Y, Shan YM, Zhang GN, Fan Y, Zha X, Kong W, Gynecol Oncol 2007 2007 104 77 85
22. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A, BMC Infect Dis 2009 191 1 6
23. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Munoz N, Bosch FX, Castellsague X, Diaz M, De Sanjose S, Hammouda D, Int J Cancer 2004 111 278 85 10.1002/ijc.20244 15197783
24. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, De Sanjose S, Bruni L, Vaccine 2008 10 1 16
25. PCR detection and high risk typing of human papillomavirus DNA in cervical cancer in Iranian women. Eslami G, Golshani M, Rakhshan M, Fallah F, Goudarzi H, Taghavi A, Cancer Therapy 2008 6 361 366
26. Human papillomavirus (HPV) detection in biopsies from cervical cancer patients; A population-based study from Iran. Niakan M, Yarandi F, Entezar M, Iran J Clin Infect Dis 2009 4 35 37
27. The prevalence of human papillomavirus in cervical cancer in Iran. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A, Asian Pac J Cancer Prev 2002 3 1 69 72 12718611
28. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Pirog EC, Kleter B, Olgac S, Am J Pathol 2000 157 1055 1062 10.1016/S0002-9440(10)64619-6 11021808
29. WHO ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), Human papillomavirus and related cancers in Senegal Summary report update. 2010 http://www.who.int/hpvcentre